XML 75 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:        
Net loss $ (1,627,483) $ (4,029,860) $ (4,030,641) $ (1,593,173)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 85,563 72,476 151,007 51,180
Amortization of investment premium    5,348 6,205 8,734
Stock-based compensation expense 445,069 609,793 1,129,960 438,395
Mark-to-market adjustment on warrant liability (1,171,250) 1,171,250 679,325 (2,038,000)
Loss on disposal of fixed assets    16,885 16,885 453
Changes in operating assets and liabilities:        
Restricted cash (270,211) (105,000) (105,000)   
Credit card holdback receivable 30,369 (31,954) 154,547 (202,388)
Accounts receivable, net (13,163) (69,992) 160,171 (356,177)
Accrued interest paid       5,907 (5,907)
Prepaid expense and other current assets 34,688 (96,833) (108,009) (22,554)
Security deposit    19,520 19,520 (1,335)
Accounts payable and accrued expenses and other current liabilities 341,601 235,007 (843,470) 960,266
Deferred rent (14,587) (11,135) (23,421) 102,115
Deferred revenue (492,527) 516,537 (614,177) 1,200,491
Accrued interest payable - related party          2,358
Net cash used in operating activities (2,651,931) (1,697,958) (3,401,191) (1,455,542)
Cash flows from investing activities:        
Purchase of fixed assets (35,550) (88,241) (137,978) (540,591)
Purchase of non-marketable equity securities (50,000) 0      
Redemption of short-term investments 0 4,975,000 6,475,000 (6,489,937)
Repayment of notes receivable issued to employees      11,320   
Repayment (issuance) of notes receivable and accrued interest (2,382) 7,672 (38,233) (138,803)
Net cash (used in) provided by investing activities (87,932) 4,894,431 6,310,109 (7,169,331)
Cash flows from financing activities:        
Proceeds from issuance of common stock and warrants          7,915,700
Proceeds from exercise of common stock warrants          88,125
Proceeds from exercise of stock options       50,850   
Net cash provided by financing activities       50,850 8,003,825
Net (decrease) increase in cash and cash equivalents (2,739,863) 3,196,473 2,959,768 (621,048)
Cash and cash equivalents at beginning of year 5,357,596 2,397,828 2,397,828 3,018,876
Cash and cash equivalents at end of period 2,617,733 5,594,301 5,357,596 2,397,828
Supplemental disclosure of cash flow information:        
Cash paid for taxes and related interest       15,640 4,500
Supplemental disclosure of noncash activity:        
Conversion of notes and accrued interest to common stock          71,959
AYI.com domain purchase in exchange for 100,000 shares of common stock $ 100,000